LORI GONZALES: Open Payments
NPI 1972870178 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,662 in 112 payments from 15 companies in 2025. Trend: 2023 $1,810 · 2024 $695 · 2025 $1,662
Food & beverage: $1,662
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $449 |
| Otsuka America Pharmaceutical, Inc. | 31 | $307 |
| Lundbeck LLC | 21 | $254 |
| Axsome Therapeutics, Inc. | 9 | $198 |
| E.R. Squibb & Sons, L.L.C. | 6 | $135 |
| Teva Pharmaceuticals USA, Inc. | 6 | $115 |
| Alkermes, Inc. | 2 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: REXULTI, VRAYLAR, Auvelity, COBENFY, UZEDY, ABILIFY MAINTENA, ARISTADA, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
